Unlock instant, AI-driven research and patent intelligence for your innovation.

The preparation method of everolimus intermediate

A technology for everolimus and intermediates, which is applied in the field of preparation of pharmaceutical intermediates, and can solve the problem of low yield and purity of tert-butyldimethylhydroxyethoxysilane, the product of ethylene glycol mono-substitution, and ethylene glycol double-substitution. There are many by-products, etc., to achieve high yield, improve purity, and reduce degradation

Active Publication Date: 2019-11-15
CHANGZHOU LANLING PHARMA
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The deficiency of this method is: because two hydroxyl groups of ethylene glycol all can react with tert-butyl dimethyl chlorosilane, and the method of this document does not carry out effective control to this, thereby cause ethylene glycol disubstituted by-product relatively More, which in turn leads to lower yield and purity of ethylene glycol monosubstituted product tert-butyldimethylhydroxyethoxysilane

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1)

[0016] The preparation method of the everolimus intermediate of the present embodiment has the following steps:

[0017] ①Add 13g of tert-butyldimethylchlorosilane to 26.1g of dichloromethane, stir until dissolved to obtain a dichloromethane solution of tert-butyldimethylsilyl chloride; Diol, 78.3g of dichloromethane and 36.7g of pyridine were cooled to -30°C, and the above dichloromethane solution of tert-butyldimethylsilyl chloride was added dropwise, and the reaction was continued for 30 minutes after the dropwise completion.

[0018] After the reaction is over, add a phosphoric acid-potassium dihydrogen phosphate buffer solution with a concentration of 10wt% to adjust the pH of the reaction system to 2, then adjust the pH of the reaction system to 6 with saturated saline, let it stand, collect the organic phase, add a desiccant to dry, and filter , concentrated to obtain 16.9g of 2-(tert-butyldimethylsilyloxy)ethanol, the weight yield was 130%, the content detected by GC w...

Embodiment 2~ Embodiment 6)

[0022] The method of each embodiment is basically the same as that of Example 1, except for step ①, see Table 1 for details.

[0023] Table 1

[0024] Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 organic base pyridine 2,6-Lutidine pyridine 2,6-Lutidine pyridine 2,6-Lutidine inert solvent Dichloromethane Dichloromethane benzene benzene Chloroform Chloroform temperature reflex -30℃ -35℃ -25℃ -30℃ -35℃ -25℃ 2-(tert-Butyldimethylsilyloxy)ethanol 16.9g 16.2g 17.1g 16.4g 15.6g 16.0g Mono-substituted product content 85.0% 84.5% 82.5% 83.0% 84.0% 83.5% molar yield 94.5% 90.0% 92.8% 89.5% 86.2% 87.9% Double substitution by-product content 3.45% 3.74% 3.60% 3.98% 4.25% 3.76%

Embodiment 7)

[0026] The method of this embodiment is basically the same as that of Embodiment 1, the difference lies in step ①:

[0027] Add 13g of tert-butyldimethylsilyl chloride to 26.1g of dichloromethane, stir until dissolved to obtain a dichloromethane solution of tert-butyldimethylsilyl chloride; add 52.2g of ethylene dichloride to the reaction device Alcohol, 78.3g of dichloromethane and 36.7g of pyridine were cooled to -30°C, and the above dichloromethane solution of tert-butyldimethylsilyl chloride was added dropwise, and the reaction was continued for 30 minutes after the dropwise completion.

[0028] After the reaction, directly adjust the pH of the reaction system to 6, let it stand, collect the organic phase, add a desiccant to dry, filter, and concentrate to obtain 16.5 g of 2-(tert-butyldimethylsiloxy)ethanol, the weight yield It was 127%, and the GC detection content was 81.5%, and the molar yield was 88.5%, and the GC detection double-substituted by-product content was 4....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of an everolimus intermediate. The preparation method comprises the following steps: reacting ethylene glycol and tert-butyldimethylsilyl chloride in inert solvents such as dichloromethane at the temperature of 35 DEG C below zero to 25 DEG C below zero in the presence of organic base to obtain 2-(tert-dimethylsiloxy)ethyl alcohol; reacting the 2-(tert-dimethylsiloxy)ethyl alcohol and trifluoromethanesulfonic anhydride in the presence of the organic base to obtain trifluoromethanesulfonic acid 2-(tert-dimethylsiloxy)ethyl ester. According to the method disclosed by the invention, the generation of a disubstituted by-product can be greatly reduced, and further a monosubstituted product 2-(tert-dimethylsiloxy) ethyl alcohol with relatively-high purity and yield is obtained.

Description

technical field [0001] The invention belongs to the technical field of preparation of pharmaceutical intermediates, in particular to a preparation method of everolimus intermediates. Background technique [0002] Everolimus is an orally effective derivative of rapamycin developed by Novartis, Switzerland, and belongs to a new generation of macrolide immunosuppressants and anti-tumor drugs. Everolimus was first launched in Sweden in 2003, as an immunosuppressant to prevent rejection in organ transplantation and as a coating drug for drug coating of vascular stents. Everolimus was approved by the European Medicines Agency (EMEA) and the U.S. Food and Drug Administration (FDA) in 2008 and 2009, respectively, as an antineoplastic drug for the treatment of breast cancer, neuroendocrine tumors and renal cell carcinoma. [0003] 2-(tert-butyldimethylsilyloxy)ethyl trifluoromethanesulfonate is an important intermediate for the preparation of everolimus (see US patent document US566...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07F7/18
CPCC07F7/1804C07F7/188
Inventor 徐芳芳吴文强
Owner CHANGZHOU LANLING PHARMA